252 related articles for article (PubMed ID: 28351333)
1. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
[TBL] [Abstract][Full Text] [Related]
2. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
3. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
5. HnRNPA2B1 promotes the proliferation of breast cancer MCF-7 cells via the STAT3 pathway.
Gao LB; Zhu XL; Shi JX; Yang L; Xu ZQ; Shi SL
J Cell Biochem; 2021 Apr; 122(3-4):472-484. PubMed ID: 33399232
[TBL] [Abstract][Full Text] [Related]
6. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
[TBL] [Abstract][Full Text] [Related]
7. Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer.
Yang Y; Wei Q; Tang Y; Yuanyuan Wang ; Luo Q; Zhao H; He M; Wang H; Zeng Q; Lu W; Xu J; Liu T; Yi P
Cancer Lett; 2020 Apr; 475():43-52. PubMed ID: 32006618
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
9. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
10. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
Yu SJ; Long ZW
Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
[TBL] [Abstract][Full Text] [Related]
11. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
[TBL] [Abstract][Full Text] [Related]
13. Identification of anti-tumoral feedback loop between VHLα and hnRNPA2B1 in renal cancer.
Liu Y; Zhang H; Li X; Zhang C; Huang H
Cell Death Dis; 2020 Aug; 11(8):688. PubMed ID: 32826868
[TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
[TBL] [Abstract][Full Text] [Related]
15. 15α-methoxypuupehenol Induces Antitumor Effects
Hilliard TS; Miklossy G; Chock C; Yue P; Williams P; Turkson J
Mol Cancer Ther; 2017 Apr; 16(4):601-613. PubMed ID: 28069875
[TBL] [Abstract][Full Text] [Related]
16. Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer.
Kunigal S; Lakka SS; Sodadasu PK; Estes N; Rao JS
Int J Oncol; 2009 May; 34(5):1209-20. PubMed ID: 19360334
[TBL] [Abstract][Full Text] [Related]
17. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
[TBL] [Abstract][Full Text] [Related]
18. Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway.
Ahn HJ; Kim G; Park KS
Biochem Biophys Res Commun; 2013 Aug; 437(4):557-64. PubMed ID: 23850691
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer.
Lim S; Yoo BK; Kim HS; Gilmore HL; Lee Y; Lee HP; Kim SJ; Letterio J; Lee HG
BMC Cancer; 2014 Dec; 14():928. PubMed ID: 25491510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]